Showing 263 microbiome trials
Intestinal Disease
The gut microbiota plays a crucial role in human health, influencing metabolism, immunity, and pathogen resistance. Rese…
Rome, ItalyEst. completion Mar 10, 2027
Gastro-Intestinal Disorder
Currently, ANSM recommendations govern FMT (Fecal Microbiota Transplantation) in clinical trials. The collection and val…
Paris, FranceEst. completion May 2030
Graft Versus Host DiseaseHematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
This study evaluates the factors that contribute to chronic graft-versus-host disease, which is a complication that can …
Duarte, United StatesEst. completion Jan 17, 2030
Fecal Microbiota TransplantationCesarean SectionOverweight and Obesity
This single-center randomized controlled trial evaluates whether donor-derived fecal microbiota transplantation (FMT) ad…
Oulu, FinlandEst. completion Mar 31, 2031
Decompensated Cirrhosis
This is a phase III, multicenter, double-blind, placebo-controlled, randomized clinical trial to evaluate the safety and…
Barcelona, SpainEst. completion Jan 2029
Gastro-Intestinal Disorder
The study participant is being asked to take part in this clinical trial, a type of research study, because the particip…
Memphis, United StatesEst. completion Dec 31, 2026
ColitisDiarrheaMalignant Genitourinary System NeoplasmMelanomaLung CancerOvarian CancerUterine CancerBreast CancerCervical Cancer
This trial studies how well fecal microbiota transplantation works in treating diarrhea or colitis (inflammation of the …
Houston, United StatesEst. completion Dec 31, 2027
Helicobacter Pylori Infection
To determine whether regulating the gut microbiota can contribute to the eradication of refractory H. pylori infection.
Chengdu, ChinaEst. completion Dec 31, 2026
Clinical Stage 0 Cutaneous Melanoma AJCC v8Clinical Stage I Cutaneous Melanoma AJCC v8Clinical Stage IA Cutaneous Melanoma AJCC v8Clinical Stage IB Cutaneous Melanoma AJCC v8Clinical Stage II Cutaneous Melanoma AJCC v8Clinical Stage IIA Cutaneous Melanoma AJCC v8Clinical Stage IIB Cutaneous Melanoma AJCC v8Clinical Stage IIC Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8ColitisLung Non-Small Cell CarcinomaMalignant Genitourinary System NeoplasmMalignant Solid NeoplasmPathologic Stage 0 Cutaneous Melanoma AJCC v8
Primary Sclerosing CholangitisLiver DiseasesCholangitis, Sclerosing
Primary sclerosing cholangitis (PSC) is a rare liver disease that damages the liver's bile ducts. Bile ducts are tiny tu…
Los Angeles, United StatesEst. completion May 31, 2029
Hematologic Neoplasms
Background:
People with blood cancers often receive blood or bone marrow transplants. But even with these treatments, t…
Bethesda, United StatesEst. completion Jul 3, 2028
Liver Disease; Alcohol-RelatedCirrhosisAlcohol Use Disorder
The purpose of this research study is to test the safety, tolerability, and effectiveness of the capsules that contain b…
Richmond, United StatesEst. completion May 2027
End Stage Liver Disease
This will be a prospective cohort study of patients with liver disease. Subjects will undergo geriatric assessments of f…
Little Rock, United StatesEst. completion Dec 31, 2030
Functional Gastrointestinal Disorders
Safety and efficacy of FMT in Pediatric Functional Gastrointestinal Disorders
Wuhan, ChinaEst. completion Aug 1, 2026
Crohn Disease
This study will test the safety and effectiveness of fecal microbiota transplantation (FMT) plus partial enteral nutriti…
Wuhan, ChinaEst. completion May 31, 2027
Clostridioides Difficile Infection
The clinical trial aims to evaluate the efficacy of fecal microbiota transplantation (FMT) after standard of care treatm…
Basel, SwitzerlandEst. completion Apr 1, 2027
Crohn Disease
To explore the safety and effectiveness of repeated and multiple fecal microbiota transplantations (FMTs) plus partial e…
Wuhan, ChinaEst. completion Jun 30, 2027
Ulcerative Colitis
This study included two topics: one was to test the efficacy and safety of fecal microbiota transplants plus partial ent…
Wuhan, ChinaEst. completion Jun 30, 2026
Amyotrophic Lateral Sclerosis ALS
This is a 24-week study of intestinal microbiome transplant in people with ALS. All participants will be evaluated clini…
Durham, United StatesEst. completion Nov 1, 2026
Lymphoma Receiving CAR-T Therapy
This is a single site pilot trial will evaluate the feasibility and safety of fecal microbiota transplantation (FMT) in …
Toronto, CanadaEst. completion Jun 2, 2029
Pathologic Stage I Cutaneous Melanoma AJCC v8
Pathologic Stage IA Cutaneous Melanoma AJCC v8
Pathologic Stage IB Cutaneous Melanoma AJCC v8
Pathologic Stage II Cutaneous Melanoma AJCC v8
Pathologic Stage IIA Cutaneous Melanoma AJCC v8
Pathologic Stage IIB Cutaneous Melanoma AJCC v8
Pathologic Stage IIC Cutaneous Melanoma AJCC v8
Pathologic Stage III Cutaneous Melanoma AJCC v8
Pathologic Stage IIIA Cutaneous Melanoma AJCC v8
Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
Pathologic Stage IIIC Cutaneous Melanoma AJCC v8
Pathologic Stage IIID Cutaneous Melanoma AJCC v8
Pathologic Stage IV Cutaneous Melanoma AJCC v8
Stage 0 Lung Cancer AJCC v8
Stage I Lung Cancer AJCC v8
Stage IA1 Lung Cancer AJCC v8
Stage IA2 Lung Cancer AJCC v8
Stage IA3 Lung Cancer AJCC v8
Stage IB Lung Cancer AJCC v8
Stage II Lung Cancer AJCC v8
Stage IIA Lung Cancer AJCC v8
Stage IIB Lung Cancer AJCC v8
Stage III Lung Cancer AJCC v8
Stage IIIA Lung Cancer AJCC v8
Stage IIIB Lung Cancer AJCC v8
Stage IIIC Lung Cancer AJCC v8
Stage IV Lung Cancer AJCC v8
Stage IVA Lung Cancer AJCC v8
Stage IVB Lung Cancer AJCC v8
This trial studies the role of the gut microbiome and effectiveness of a fecal transplant on medication-induced gastroin…
Houston, United StatesEst. completion Oct 31, 2026